BMO Capital Upgrades Replimune Group (REPL) to Outperform

June 30, 2026 4:04 AM

BMO Capital analyst Evan Seigerman upgraded Replimune Group (NASDAQ: REPL) from Market Perform to Outperform with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found